Prostate Health Index for Prostate Cancer Diagnosis

CompletedOBSERVATIONAL
Enrollment

472

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

September 19, 2018

Study Completion Date

October 19, 2018

Conditions
Prostate Cancer
Interventions
DEVICE

Measurement of Prostate Health Index (PHI)

Use of a diagnostic tool to predict prostate biopsy outcome: measurement of total and free PSA as well as the \[-2\]proPSA and calculation of The Prostate Health Index according to the following formula: Prostate Health Index (PHI) = \[p2PSA /fPSA\] x √tPSA

Trial Locations (10)

69495

Unité Médicale d'Oncologie et de Transfert - Service de Biochimie et Biologie Moléculaire - Centre Hospitalier Lyon-Sud, Pierre-Bénite

Unknown

CHU Mondor, Créteil

CHU Kremlin-Bicêtre, Le Kremlin-Bicêtre

Clinique Louvière de Lille, Lille

Hôpital Edouard Herriot, Lyon

Clinique Beau Soleil, Montpellier

Hôpital Tenon, Paris

CHU de Rennes, Rennes

Clinique Atlantis, Saint-Herblain

IUCT Oncopole de Toulouse, Toulouse

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03151356 - Prostate Health Index for Prostate Cancer Diagnosis | Biotech Hunter | Biotech Hunter